Becton Dickinson's Acquisition of Edwards Lifesciences' Unit for $4.2 Billion in Cash
Monday, 3 June 2024, 12:25
Becton Dickinson to Acquire Edwards Lifesciences' Unit for $4.2 Billion in Cash
In a significant financial development, Becton Dickinson has made a noteworthy move by acquiring Edwards Lifesciences' unit for $4.2 billion in cash. This strategic acquisition is set to redefine the dynamics of the healthcare sector.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.